The most credible up-to-date information about Low Dose Naltrexone (LDN) for Physicians, Researchers, and Patients

Learn about LDN

Learn about LDN, what it's used for, how it works, its discovery timeline and the researchers that stand behind it

Access all the scientific studies about LDN. Whether lab research, animal studies or human trials, we have it all available here.

Free global directory of LDN prescribers.
Search for a LDN-experienced practitioner nearby.

Preparing LDN requires special expertise and experience.
Find an expert pharmacy that knows how to prepare LDN.

Have you benefited from LDN?
Help advance LDN research and education with a tax-deductible online donation. DONATE

Curious how LDN works? This video demonstrates the scientific understanding of how LDN triggers beneficial health effects.

Sign up for news alerts

Moshe Rogosnitzky

Research Scientist, Innovator and Inventor

Dipyridamole eye drop treatment results presented at ISVER

MedInsight presented its research findings on Dipyridamole eye drops at the recent ISVER conference at Kfar Maccabia. For more details see MedInsight LinkedIn Page
MedInsight article in Journal of Ocular Pharmacology and Therapeutics

MedInsight recently published a comprehensive review of Dipyridamole in Ocular use in the prestigious Journal of Ocular Pharmacology and Therapeutics. To read the full text, click the link.
Follow MedInsight on Linkedin

MedInsight has added a Linkedin page, so that you can keep abreast of all our activities, news, updates and research! Visit our page by clicking on the following link.
New Dipyridamole eye drop clinical trial at Wolfson Medical Center

Our first clinical trial for Dipyridamole eye drop is on track to begin at Wolfson Medical Center's Department of Ophthalmology. This is the first ever clinical trial for a non-surgical treatment for pterygium, and will also measure the effectiveness in dry eye. For more information about Dipyridamole eye drops click here
MedInsight at ISVER conference

MedInsight has been invited to present at the 2016 ISVER conference. Our presentation, entitled “Topical Dipyridamole for Treatment of Pterygium and Associated Dry Eye Symptoms: Analysis of User-Reported Outcomes” will outline the user outcomes thus far. For information about the conference click here.